Abstract

Nanotheranostics that incorporate therapeutic and biomarker moieties in single nanoplatform show wide-scale possibility for noninvasive diagnosis, real-time monitoring, and treatment of brain cancer. This review discusses the application of different classified nanoparticles as theranostics for brain cancer. This includes magnetic nanoparticles, metallic nanoparticles (gold nanoparticles, silver nanoparticles, mesoporous silica nanoparticles, and quantum dots), polymeric nanoparticles, liposomes, and lipid nanoparticles (solid lipid nanoparticles and nanostructured lipid carriers). No doubt nanotheranostics provide futuristic scope for diagnosis and treatment of brain cancer; still improvement in regulatory affairs, collaboration of different sectors such as private or government are required for successful conversion of nanotheranostics concept into clinical studies.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.